Association study of hypoxia inducible factor 1α (HIF1α) with osteonecrosis of femoral head in a Korean population

[1]  M. Hirakawa,et al.  Risk factors for dysbaric osteonecrosis. , 2006, Rheumatology.

[2]  G. Semenza,et al.  Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. , 2006, Physiological genomics.

[3]  A. Battmann,et al.  Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  M. Akagi,et al.  Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF‐1α/vascular endothelial growth factor system , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  Daekyu Sun,et al.  Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter. , 2005, Biochemistry.

[6]  Hong Zhu,et al.  Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. , 2005, Chinese journal of digestive diseases.

[7]  S. Childs.  Osteonecrosis: death of bone cells. , 2005, Orthopedic nursing.

[8]  G. Bubley,et al.  Identification of hypoxia‐inducible factor‐1α (HIF‐1α) polymorphism as a mutation in prostate cancer that prevents normoxia‐induced degradation , 2005, The Prostate.

[9]  D. Hungerford,et al.  Asymptomatic osteonecrosis: should it be treated? , 2004, Clinical orthopaedics and related research.

[10]  J. Block,et al.  Hypoxia induces HIF‐1α and VEGF expression in chondrosarcoma cells and chondrocytes , 2004 .

[11]  A. Demaine,et al.  Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. , 2004, Cancer genetics and cytogenetics.

[12]  P. Jaakkola,et al.  Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. , 2004, The Biochemical journal.

[13]  Shih-Feng Tsai,et al.  Autosomal dominant avascular necrosis of femoral head in two Taiwanese pedigrees and linkage to chromosome 12q13. , 2004, American journal of human genetics.

[14]  J. Boss,et al.  Experimentally gained insight - based proposal apropos the treatment of osteonecrosis of the femoral head. , 2004, Medical hypotheses.

[15]  H. Raff,et al.  Metabolomic analysis of adrenal lipids during hypoxia in the neonatal rat: implications in steroidogenesis. , 2004, American journal of physiology. Endocrinology and metabolism.

[16]  M. Hadjiargyrou,et al.  Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. , 2004, Bone.

[17]  T. Kubo,et al.  Genetic analysis of steroid-induced osteonecrosis of the femoral head , 2003, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[18]  Zhaohui S. Qin,et al.  Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. , 2002, American journal of human genetics.

[19]  R. Ganz,et al.  Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients1 , 2002, Transplantation.

[20]  Y. Shoenfeld,et al.  Pathogenesis and natural history of osteonecrosis. , 2002, Seminars in arthritis and rheumatism.

[21]  S. Yamashita,et al.  Lipid Accumulation in Smooth Muscle Cells Under LDL Loading Is Independent of LDL Receptor Pathway and Enhanced by Hypoxic Conditions , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Gwo‐Jaw Wang,et al.  Risk Period for Developing Osteonecrosis of the Femoral Head in Patients on Steroid Treatment , 2002, Clinical Rheumatology.

[23]  T Kobayashi,et al.  Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. , 2001, Genes & development.

[24]  G. Semenza,et al.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.

[25]  C. Glueck,et al.  Hypofibrinolysis, Thrombophilia, Osteonecrosis , 2001, Clinical orthopaedics and related research.

[26]  G. Semenza.  HIF-1 and mechanisms of hypoxia sensing. , 2001, Current opinion in cell biology.

[27]  G. Semenza,et al.  HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.

[28]  C. Glueck,et al.  The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. , 1999, Clinical orthopaedics and related research.

[29]  R. Sierra,et al.  Osteonecrosis of the femoral head. , 1999, The Journal of the American Academy of Orthopaedic Surgeons.

[30]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[31]  D. Hungerford,et al.  Osteonecrosis of the femoral head : potential treatment with growth and differentiation factors , 1998 .

[32]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[33]  Jessica Lo,et al.  HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .

[34]  G. Semenza,et al.  Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. , 1996, The American journal of physiology.

[35]  G. Semenza,et al.  Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. , 1994, The Journal of biological chemistry.

[36]  B. Skikne,et al.  Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip , 1993, American journal of hematology.

[37]  Y. Sugioka,et al.  Influence of Alcohol Intake, Cigarette Smoking, and Occupational Status on Idiopathic Osteonecrosis of the Femoral Head , 1988, Clinical orthopaedics and related research.

[38]  K. Malizos,et al.  The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head. , 2002, Haematologica.